Depression is common in people with inflammatory bowel disease (IBD), but the actual causes of depression in this group are unknown. In a Neurogastroenterology & Motility study, depression was linked with more severe IBD symptoms, and a less positive cognitive bias in emotional recognition (a reduced ability to recognize basic emotions in others) was involved in this association.
Depression is common in people with inflammatory bowel disease (IBD), but the actual causes of depression in this group are unknown. In a Neurogastroenterology & Motility study, depression was linked with more severe IBD symptoms, and a less positive cognitive bias in emotional recognition (a reduced ability to recognize basic emotions in others) was involved in this association.
The results raise the possibility that psychological interventions targeting emotional recognition biases could be used to treat or even prevent depression in high-risk individuals with IBD.
“These findings are preliminary but suggest that negative cognitive biases associated with IBD activity may lead to the development of depression in people with IBD. Our results could indicate novel ways to treat or even prevent depression in people with IBD, though our findings require replication in prospective studies, which will allow us to draw stronger inferences on the causal association of cognitive biases with depression,” said senior author Chris Dickens, PhD, of the University of Exeter, in the UK.
Additional Information
Link to Study: https://onlinelibrary.wiley.com/doi/10.1111/nmo.13647
About Journal
Neurogastroenterology & Motility publishes original research and topical reviews (commissioned), in English, on basic and clinical aspects of, gastrointestinal motility and its control by myogenic, neural and chemical mechanisms, as well as basic and clinical aspects of brain-gut interactions and on how the central, autonomic and/or enteric nervous systems interact in the control of gastrointestinal motility or other gastrointestinal functions including absorption, secretion, vasomotor function and immunology. In addition, clinical trials papers, focused editorial viewpoints (commissioned), abstracts of symposia, meeting reports and notices of ANMS and ESNM business and matters of interest to members are published.
Wiley drives the world forward with research and education. Our scientific, technical, medical, and scholarly journals and our digital learning, certification, and student-lifecycle services and solutions help students, researchers, universities, and corporations to achieve their goals in an ever-changing world. For more than 200 years, we have delivered consistent performance to all of our stakeholders. The Company's website can be accessed at www.wiley.com.
Penny Smith +44 (0) 1243 770448 (UK)
newsroom@wiley.com